Health+Benefits

How Disruptive is Medicare for All?

It’s no secret that a government-controlled healthcare system would be disruptive—not only to the 156 million Americans with employer-sponsored healthcare, but also to those whom would be taxed to fund the system, which is how the proposed arrangements would operate sans copays or cost sharing.
By Katie Oberkircher Posted on December 5, 2018

It’s no secret that a government-controlled healthcare system would be disruptive—not only to the 156 million Americans with employer-sponsored healthcare, but also to those whom would be taxed to fund the system, which is how the proposed arrangements would operate sans copays or cost sharing. What we know is that there are at least six Medicare expansion plans before Congress. Single-payer legislation establishes one government-administered health plan, while public option bills would allow a government option to be sold alongside private options. Check out our breakdown:

Note: We recognize that when the next Congress begins in January, other single-payer and public option proposals may be introduced.

Sources: Kane, Arielle. “Progressives and Health Care: What Comes Next?” Progressive Policy Institute, 24 Oct. 2018, www.progressivepolicy.org/publications/progressives-and-health-care-what-comes-next/.

For more details, see this memo created by our legal team at Steptoe & Johnson.

Want to know what individual states are doing? Click here to see single-payer and public option proposals at the state level.

Katie Oberkircher Director, Market Intelligence & Insights Read More

More in Health+Benefits

Evaluating the Data on Digital Health
Health+Benefits Evaluating the Data on Digital Health
Q&A with Adam Cohen, MD, Assistant Professor of Neurology, Johns Hopkins Medicin...
Identifying the (Benefits) Gaps
Health+Benefits Identifying the (Benefits) Gaps
Three steps employers can take to move toward an inclusive culture
Do Bipartisan Healthcare Cost Solutions Exist?
Health+Benefits Do Bipartisan Healthcare Cost Solutions Exist?
A D.C. insider’s perspective on the chances of major drug pricing and ACA refo...
David Axelrod
Health+Benefits David Axelrod
On the future of the ACA, prescription drugs, pollsters, and...
The Compounding Business
Health+Benefits The Compounding Business
Q&A with Tara Thompson, Pharmacist and Vice President of Cli...